Skip to content
akaturk Academic measurement
Search
Articles 7 YÖKSİS 7 · OpenAlex 0 Total citations 71 h-index 5 · OpenAlex OpenAlex coverage %86 matched 6 / 7 Q1 articles 0 Scopus · WoS Q1 0 Co-authors 14 1 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 6 + YÖKSİS · co-author record: 1
h-index 5 Percentile in Türkiye: 52 #182 of 657 at their university by h-index
i10-index
2
Total citations
71
Top 44% in Türkiye
Per article
10.1
FWCI
0.88
1.00 = world average
World top 1%
0
World top 10%
0
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (7 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 4.

Citing publications Crossref 9 publications citing 6 DOI-bearing articles · 2 Türkiye-affiliated
  • 2019 2
  • 2020 2
  • 2021 4
  • 2022 1
  1. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions TR Abdelhakim Bouyahya et al. · Biomolecules · 2022
  2. DOI 10.3389/fphar.2021.757120 2021
  3. DOI 10.1016/j.biopha.2021.111730 2021
  4. DOI 10.1016/j.bioactmat.2021.02.015 2021
  5. DOI 10.1002/jmv.26787 2021
  6. Akrep Hemolenfinin Kanser Hücrelerinde Antiproliferatif ve Morfolojik Etkilerinin Araştırılması TR Arzu İŞCAN et al. · Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi · 2020
  7. DOI 10.1016/j.lfs.2020.117466 2020
  8. DOI 10.1016/j.jss.2019.05.038 2019
  9. DOI 10.1038/s41419-019-1306-x 2019
Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Works 7

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%0
Avg · n 6 %70.2
Other counts

Scopus (SJR)

  • YÖKSİS rows 5

WoS (JCR)

  • YÖKSİS rows 5

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

7articles

Journals with publications

6 journals

Narrow down

Scopus (SJR)
Q10 Q24 Q30 Q41
WoS (JCR)
Q10 Q22 Q32 Q41
TR Index
0articles

Article list

  1. 2025 Combined treatment with ruxolitinib and MK-2206 inhibits ERa activity by inhibiting MAPK signaling in BT474 breast cancer cells Journal of Investigative Medicine DOI 10.1177/10815589241298184 YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.5%
  2. 2024 Ruxolitinib-loaded poly-ɛ-caprolactone (PCL) nanoparticles inhibit JAK2/STAT5 signaling in BT474 breast cancer cells by downregulating Bcl-2 and Mcl-1 Molecular Biology Reports DOI 10.1007/s11033-024-09764-3 YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.7%
  3. 2023 Combined treatment with ruxolitinib and MK‑2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA‑MB‑231 breast cancer cell line Molecular Biology Reports DOI 10.1007/s11033-022-08034-4 YÖKSİS SJR Q2 JCR Q3 OpenAlex 83.9%
  4. 2021 Estradiol differentially regulates DUX4, β-catenin and PAX3/PAX7 in primary myoblasts of facioscapulohumeral muscular dystrophy patients Turkish Journal of Biochemistry-Turk Biyokimya Dergisi DOI DOI: https://doi.org/10.1515/tjb-2020-0351. YÖKSİS SJR Q4 JCR Q4
  5. 2019 Triple Effect of Doxorubicin, 5-Fluorouracil, Propranolol on Cell Survival on MCF-7 Breast Cancer Cell Line Journal of Biosciences and Medicines DOI 10.4236/jbm.2019.72007. YÖKSİS OpenAlex 68.6%
  6. 2019 Investigation of Methylation Profiles of TP53, Caspase 9, Caspase 8, Caspase 3 Genes Treated with DNA Methyl Transferase Inhibitor (DNMTi) Zebularine (ZEB) and Caffeic Acid Phenethyl Ester (CAPE) on MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Journal of Cancer Therapy DOI doi: 10.4236/jct.2019.101006 YÖKSİS OpenAlex 50.1%
  7. 2014 Inhibition of autophagy by 3 MA potentiates purvalanol induced apoptosis in Bax deficient HCT 116 colon cancer cells Experimental Cell Research DOI 10.1016/j.yexcr.2014.07.022 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.4%

Projects 7 See all (7) →

  1. 2025 Ruxolitinib’in Tamoksifen Dirençli BT474 Meme Kanseri Hücre Hatlarında JAK2/STAT5 Metilasyonu Üzerindeki Etkisinin İncelenmesi -Tübitak 2209 · Tamamlandı 2025-04-08 – 2026-07-08
  2. 2024 Ruxolitinib'in Tamoksifen Dirençli BT474 Meme Kanseri Hücre Hatlarındaki Epigenetik Hedeflerinin Araştırılması -Tübitak 2209 · Tamamlandı 2024-03-22 – 2025-09-22
  3. 2024 Ruxolitinib ve MK-2206 kombine uygulamasının MDA-MB-231 meme kanseri hücrelerinde EMT sürecindeki rolünün incelenmesi Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2024-03-15 – 2025-07-03
  4. 2019 Mocetinostat, Ruxolitinib, MK2206 Ve Capacitabine’xxnin Tekli Ve Kombine Uygulamalarının Meme Kanseri Hücre Hatları Olan BT474, MDA-MB-436 Ve 4T1 Üzerine Etkilerinin Araştırılması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2019-02-15 – 2023-07-21
  5. 2017 Fonksiyonel Vaskülarize Miyokardiyum Dokusu Oluşturulmasına Yönelik İndüklenmiş Pluripotent Kök Hücrelerinin Kullanılması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2017-03-15 – 2018-09-15

Proceedings 36 See all (36) →

  1. 2015 Kafeik asit fenetil ester ve DNA metil transferaz inhibitörü zebularin in MDA MB 231 meme kanser hücre hattındaki sitotoksik etkisinin ve epigenetik süreçteki kontrolünün incelenmesi XIV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi
  2. 2014 ASSOCİATİON OF DNA METHYLATION OF P16INK4A CDKN2A AND MGMT GENES AND HISTOPATHOLOGICAL FEATURES OF BREAST CANCER 3rd International Congress of the Molecular Biology Association of Turkey, 10-12 September 2014
  3. 2015 MEME KANSERİ HASTALARINDA NF KAPPA B İNHİBİTOR ALPHA GENİ POLİMORFİZMLERİNİN BfaI ENZİM KESİMİ İLE ARAŞTIRILMASI 22. ulusal biyoloji öğrenci kongresi
  4. 2015 Meme Kanseri hastalarında PCR RFLP Yöntemiyle AR Genindeki Pro12Ala Polimorfizminin İncelenmesi 22.Ulusal Biyoloji Öğrenci Kongresi
  5. 2017 Comparative effects of monotherapy and polytherapy with CAPE and Cisplatin on SKBR3 Breast cancer cell line 5TH International Bau Drug Design Congress

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
14
With an akaturk profile
4
Turkish institutions
1
Co-authored works
%100

Academic co-authors 4

  1. ONUR EROĞLU Profesör · Bilecik Şeyh Edebali Üniversitesi same university 6
  2. HACER KAYA ÇAKIR Doktor Öğretim Üyesi · Bilecik Şeyh Edebali Üniversitesi same university 3
  3. MERVE GÖZTEPE Öğretim Görevlisi (ders Vermekle Görevli) · Bilecik Şeyh Edebali Üniversitesi same university 2
  4. CEREN HANGÜL MADEN Araştırma Görevlisi · Akdeniz Üniversitesi 1

National collaboration 1 institutions

Within own university6 joint works · Bilecik Şeyh Edebali Üniversitesi

  1. Akdeniz Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 10

Arisan Elif DamlaCoker Gurkan AjdaELİF KARAÇOBANELİF KORKUTHİLMİ UYSALMUSTAFA KARABİÇİCİNAGİHAN NİZAMObakan PinarPalavan Unsal NarcinSİBEL KARAÜZÜM

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.